Prescription drug · NDA
Myqorzo (Aficamten) NDC 82112-105
Aficamten 5 mg/1 · Tablet, Film coated · Oral · Cytokinetics Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82112-105-30 | 82112010530 | 30 TABLET, FILM COATED in 1 BOTTLE (82112-105-30)Marketed from Jan 12, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Myqorzo
- Generic name (nonproprietary)
- aficamten
- Active ingredients
- Aficamten — 5 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Cytokinetics Inc.NDC labeler code 82112
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 219083
- Marketing start
- Listing expires
- Identifiers
- Product ID 82112-105_f48908e6-f578-4e6c-b4ac-d4af4f01fdd6SPL ID f48908e6-f578-4e6c-b4ac-d4af4f01fdd6SPL set ID fd778507-1274-4d1a-a659-5431d55c543aRxCUI 2731474, 2731480, 2731482, 2731484, 2731486, 2731488, 2731490, 2731492UNII B1I77MH6K1UPC 0382112115309, 0382112120303, 0382112105300
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482112010530followed by a unit qualifier and the quantityPackage 82112-0105-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 82112-105
- What is NDC 82112-105?
- 82112-105 is the product NDC for Myqorzo (aficamten), Aficamten 5 mg/1 tablet, film coated, listed with the FDA by Cytokinetics Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Myqorzo (Aficamten).
- What is the active ingredient?
- Aficamten.
- Who is the labeler?
- Cytokinetics Inc., NDC labeler code 82112. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Myqorzo?
- 3 other product NDCs are listed under this name. See all Myqorzo NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Myqorzo products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Myqorzoaficamten | Aficamten 10 mg/1 | Tablet, Film coatedOral | Cytokinetics Inc. | 82112-110 | 82112-0110-30 |
| Myqorzoaficamten | Aficamten 15 mg/1 | Tablet, Film coatedOral | Cytokinetics Inc. | 82112-115 | 82112-0115-30 |
| Myqorzoaficamten | Aficamten 20 mg/1 | Tablet, Film coatedOral | Cytokinetics Inc. | 82112-120 | 82112-0120-30 |
Other NDCs under NDA 219083
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Myqorzoaficamten | Aficamten 10 mg/1 | Tablet, Film coatedOral | Cytokinetics Inc. | 82112-110 |
| Myqorzoaficamten | Aficamten 15 mg/1 | Tablet, Film coatedOral | Cytokinetics Inc. | 82112-115 |
| Myqorzoaficamten | Aficamten 20 mg/1 | Tablet, Film coatedOral | Cytokinetics Inc. | 82112-120 |